Navigation Links
Colorcon Reaffirms World-Wide Patent Positions for Enteric Coating Compositions
Date:3/23/2011

HARLEYSVILLE, Pa., March 23, 2011 /PRNewswire/ -- Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press, particularly in India.  These communications have inaccurately summarized the status of certain patents and patent applications.   Colorcon has more than 15 patents for enteric coatings granted globally for the Acryl-EZE®, aqueous acrylic enteric, and Sureteric®, aqueous enteric systems, including valid patents in India.  These patents remain in full effect.  

"Colorcon will vigorously enforce its patent positions.  We are proud of our strong history of research and development and the resulting innovative products we provide our customers," stated Kamlesh Oza, General Manager for Film Coatings. "Colorcon endeavors to provide best-in-class products and services to the pharmaceutical industry globally.  Our recent customer survey indicates that, above all, the industry values our product range, technical support, and product use guidelines/application data.  Our intellectual property estate enables us to continue investing in the development of advanced products and continually provide the industry with next generation formulated systems with superior overall value."

About Colorcon

Colorcon is a world leader in the development, supply and support of formulated products for the pharmaceutical and nutritional industries. Its core businesses include film coatings, modified release technologies, functional excipients and tablet design services. Colorcon has 18 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base.

The patents mentioned herein are owned by BPSI Holdings, Inc.  Colorcon is the exclusive licensee.


'/>"/>
SOURCE Colorcon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
2. Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm
3. Colorcon Acquires Business of Pharmaceutical Coatings Pvt. Ltd. (India)
4. Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating
5. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
6. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
7. Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
8. CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance
9. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
10. Matrixx Initiatives, Inc. Summarizes Ongoing Go-Shop Process and Board Reaffirms Recommendation
11. DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Feb. 9, 2016  Until recently, the options for ... liposuction. Thankfully, the FDA approved the non-invasive Coolsculpting treatment, ... Coolsculpting was originally approved in 2010 for the abdomen ... now the chin. With this add-on approval, the experts ... a smaller applicator, the CoolMini, to address smaller areas ...
(Date:2/10/2016)... India , February 10, 2016 ... The "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Trends, Technologies, Participants, and Environment" research report indicates ... worth over $149 billion by 2020 growing at ... up of companion diagnostics and targeted therapeutics and ...
(Date:2/9/2016)... , Feb. 9, 2016 /PRNewswire/ - Nevro Corp. ... that is providing innovative evidence-based solutions for the treatment ... financial results for the fourth quarter and full year ... 2016. Company management will host a conference call beginning ... on Monday, February 29, 2016. www.nevro.com . ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... As part ... two webinars in February 2016. Each webinar features a dynamic expert and thoughtful ... benefit their athletes, patients and facilities. Both events are free to attend, but ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to ... this can leave patients with dental emergencies at risk of losing a tooth or ... dental care. , Common dental emergencies include:, , Avulsed ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... bring together more than 200 of the country’s top healthcare executives to share ... “The true benefit of the Forum is the provider-centric perspective, experience, expertise and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... 10, 2016 , ... Everseat has joined the award-winning Allscripts ... physicians. The integration will enable Allscripts users to post open appointments to the ... app. , The partnership gives Everseat substantial added power to help Allscripts meet ...
Breaking Medicine News(10 mins):